Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$763M |
| 2 |
Amazon
AMZN
|
+$688M |
| 3 |
TSMC
TSM
|
+$562M |
| 4 |
Tesla
TSLA
|
+$419M |
| 5 |
Johnson & Johnson
JNJ
|
+$398M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
Novo Nordisk
NVO
|
+$366M |
| 4 |
JPMorgan Chase
JPM
|
+$335M |
| 5 |
ASML
ASML
|
+$325M |
Sector Composition
| 1 | Healthcare | 20.8% |
| 2 | Technology | 15.52% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Consumer Staples | 10.11% |
| 5 | Financials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
INFI
3351
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $233K | ﹤0.01% |
419,600
-251,012
| -37% | -$139K |
|
3352
Dianthus Therapeutics
DNTH
$1.2B
| $232K | ﹤0.01% |
36,745
+11,442
| +45% | +$72.2K |
|
3353
VTEX
VTEX
$742M
| $232K | ﹤0.01% |
61,900
+32,600
| +111% | +$122K |
|
3354
Schwab US Large-Cap Value ETF
SCHV
$13.5B
| $231K | ﹤0.01% |
10,500
-27,900
| -73% | -$614K |
|
3355
Pure Cycle
PCYO
$265M
| $230K | ﹤0.01% |
21,900
-37,100
| -63% | -$390K |
|
3356
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.86B
| $229K | ﹤0.01% |
3,200
-300
| -9% | -$21.5K |
|
3357
Ryman Hospitality Properties
RHP
$6.31B
| $229K | ﹤0.01% |
+2,800
| New | +$229K |
|
3358
VirTra
VTSI
$62.9M
| $229K | ﹤0.01% |
48,900
-14,200
| -23% | -$66.5K |
|
|
CMLS
3359
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $229K | ﹤0.01% |
36,900
-16,200
| -31% | -$101K |
|
|
NOVN
3360
DELISTED
Novan, Inc. Common Stock
NOVN
| $229K | ﹤0.01% |
156,674
-118,278
| -43% | -$173K |
|
|
STSA
3361
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $229K | ﹤0.01% |
254,100
+244,100
| +2,441% | +$220K |
|
3362
Magyar Bancorp
MGYR
$110M
| $227K | ﹤0.01% |
17,700
+4,343
| +33% | +$55.7K |
|
3363
Rani Therapeutics
RANI
$23.9M
| $227K | ﹤0.01% |
+38,400
| New | +$227K |
|
|
BCEL
3364
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $227K | ﹤0.01% |
283,324
-122,553
| -30% | -$98.2K |
|
3365
Gaia
GAIA
$152M
| $224K | ﹤0.01% |
93,946
+1,046
| +1% | +$2.49K |
|
3366
Lulu's Fashion Lounge
LVLU
$12.2M
| $224K | ﹤0.01% |
5,947
+867
| +17% | +$32.7K |
|
|
ALR
3367
DELISTED
AlerisLife Inc. Common Stock
ALR
| $224K | ﹤0.01% |
406,600
-21,900
| -5% | -$12.1K |
|
3368
Ovid Therapeutics
OVID
$89.6M
| $223K | ﹤0.01% |
119,800
+1,000
| +0.8% | +$1.86K |
|
3369
Ventyx Biosciences
VTYX
$164M
| $223K | ﹤0.01% |
6,800
+1,000
| +17% | +$32.8K |
|
3370
Cocrystal Pharma
COCP
$16.2M
| $222K | ﹤0.01% |
114,028
-19,674
| -15% | -$38.3K |
|
|
IDEX
3371
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $222K | ﹤0.01% |
10,844
+1,112
| +11% | +$22.8K |
|
3372
iShares US Telecommunications ETF
IYZ
$607M
| $220K | ﹤0.01% |
+9,800
| New | +$220K |
|
3373
Global X MLP & Energy Infrastructure ETF
MLPX
$2.6B
| $220K | ﹤0.01% |
+5,400
| New | +$220K |
|
|
YQ
3374
17 Education & Technology Group
YQ
$23.7M
| $220K | ﹤0.01% |
21,591
-560
| -3% | -$5.71K |
|
3375
SPDR S&P China ETF
GXC
$502M
| $219K | ﹤0.01% |
+2,800
| New | +$219K |
|